Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BRLI-- A substantially undervalued micro-cap

No earlier versions found for this Subject.

Return to BRLI-- A substantially undervalued micro-cap

BRLI is the largest independent clinical lab in the New York area
and provides services in 17 states. The stock currently trades at
1 11/16 and sells for a p/e of just 9. Here is a copy of the last
earnings report from 9/15:

3 Mos. to July 31:
1997
1996
Revenues
9,814
8,928
Net bef. tax
413
280
Income tax
46
---
Net income
367
280
*Sh. earns.
$0.05
$0.05

9 Mos.:

Revenues
29,064
25,912
Net bef. tax
943
376
Income tax
53
49
Net income
890
327
*Sh. earns.
$0.14
$0.06

BRLI is expected to release their next earnings report in the next
two weeks. I would expect that the company could easily trade for
5-6 dollars based on valuation alone. The company is not very well
followed but is rapidly growing in an important biotechnology area.